These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11031471)

  • 1. [The morphometric characteristics of the erythrocytes and their catecholamine-binding properties in the treatment of stage-II hypertension patients with Renitec].
    Vizir AD; Ostrovskaia SV
    Lik Sprava; 2000; (5):117-21. PubMed ID: 11031471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the central hemodynamics during the treatment of hypertension with Renitec and its combination with hydrochlorothiazide].
    Malaia LT; Lapshina LA; Bil'chenko AV; Shkapo VL
    Lik Sprava; 1996; (7-9):57-60. PubMed ID: 9072267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Berlipril and Retalzem treatment of hypertension patients: the dynamics of the clinico-hemodynamic indices and of the vasodilating humoral factors].
    Koval' SN; Starchenko TG; Gorb IuG; Pen'kova MIu; Khasanova KhD
    Lik Sprava; 1999; (1):113-7. PubMed ID: 10424019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Co-renitek treatment of patients with moderate and severe forms of hypertensive disease].
    Chazova IE; Ratova LG; Dmitriev VV; Khanbalaeva MN; Kotkina TI
    Ter Arkh; 2003; 75(8):21-6. PubMed ID: 14520845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in red blood cell glutathione and glutathione-dependent enzymes on long-term treatment with captopril and enalapril.
    Golik A; Weissgarten J; Evans S; Cohen N; Zaidenstein R; Modai D; Cotariu D
    Clin Chim Acta; 1995 Aug; 240(1):89-94. PubMed ID: 8582063
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of enape combined with nebilet in hypertension].
    Gol'drin EN; Samokhina LM
    Lik Sprava; 2002; (7):104-7. PubMed ID: 12587324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of treatment with enalapril maleate on the levels of circulating catecholamines, beta endorphins, prostaglandins, and concentration of sodium in erythrocytes in patients with essential hypertension].
    Chodakowska J; Wocial B; Ignatowska-Switalska H; Knypl K; Brym E; Czerniewska E; Wacławek-Maczkowska J; Jabłońska-Skwiecińska E; Drygieniec D; Januszewicz W
    Pol Tyg Lek; 1989 Mar 20-27; 44(12-13):297-300. PubMed ID: 2554261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The activity of the neurohumoral regulatory systems, the status of the electrolyte balance and the clinical efficacy of Renitec in hypertension patients].
    Ol'binskaia LI; Pinskaia EV; Bol'shakova TD; Anastas'ina GV; Tiabenkova VF
    Ter Arkh; 1996; 68(4):54-7. PubMed ID: 9324794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of angiotensin-converting enzyme inhibitors in patients with chronic glomerulonephritis].
    Dudar IO
    Lik Sprava; 1999; (7-8):55-9. PubMed ID: 10672690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of the angiotensin-converting enzyme inhibitor Capoten on the volume-regulation indices of patients with stage-II hypertension].
    Vladkovs'kyĭ IK; Plesh IA; Haĭdukov VA; Loboda MI
    Lik Sprava; 1996; (3-4):113-7. PubMed ID: 9035842
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors.
    Djordjević VB; Pavlović D; Pejović M; Cvetković T; Lecić N; Deljanin-Ilić M
    Clin Nephrol; 1997 Apr; 47(4):243-7. PubMed ID: 9128791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of enalapril maleate on the lipid peroxidation processes and on the body's antioxidant system in patients with hypertension].
    Shapovalova SA
    Lik Sprava; 1999; (1):41-4. PubMed ID: 10423994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enalapril on lipid profile in diabetic and non-diabetic essential hypertensive patients.
    Satia MC; Shukla ML; Goyal RK
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):83-6. PubMed ID: 8864777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
    Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT
    J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of enalapril on clinical and metabolic characteristics in patients with non-insulin-dependent diabetes and arterial hypertension].
    Novikov VI; Miliagina IV
    Ter Arkh; 2000; 72(12):63-4. PubMed ID: 11201838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of enalapril in mild to moderate hypertension.
    Sharma S; Gupta U; Bapna JS; Sahai A
    J Assoc Physicians India; 1995 Jul; 43(7):475-6. PubMed ID: 8713222
    [No Abstract]   [Full Text] [Related]  

  • 19. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
    Zanchetti A; Omboni S; Di Biagio C
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S57-9. PubMed ID: 9331009
    [No Abstract]   [Full Text] [Related]  

  • 20. Selenium-dependent GSH-Px in erythrocytes of patients with hypertension treated with ACE inhibitors.
    Djordjević VB; Grubor-Lajsić G; Jovanovic-Galović A; Pavlović D; Cvetković T; Pejović M; Lecić N
    J Environ Pathol Toxicol Oncol; 1998; 17(3-4):277-80. PubMed ID: 9726802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.